|
0
|
|
Evaluation of targeted and immune combination therapies in a rat model of hormone receptor-positive breast cancer.
(pnas.org)
|
Rojas-Jimenez E
…
Polyak K
PNAS
2026-02-10
|
#modeling
#immunity
#cancer
#immunotherapy
|
|
0
|
|
Standard chemoradiotherapy with concurrent and adjuvant camrelizumab in patients with high risk nasopharyngeal carcinoma: multicentre, randomised, open label, phase 3 trial.
(bmj.com)
|
You R
…
Chen MY
BMJ
2026-02-10
|
#cancer
#clinical trial
#immunotherapy
#chemoradiotherapy
#pd-1
|
|
0
|
|
Mitochondrial transfer in the HSC-HCC-macrophage network shapes hepatocellular carcinoma progression.
(pnas.org)
|
Zhang L
…
Jiang N
PNAS
2026-02-10
|
#nanoparticles
#cancer
#immunotherapy
#microenvironment
#mitochondria
|
|
0
|
|
An interpretable molecular framework for predicting cancer driver missense mutations.
(pnas.org)
|
Yang Y
…
Li M
PNAS
2026-02-10
|
#modeling
#cancer
#mutation
#pathogenicity
|
|
0
|
|
Spatial transcriptomics reveals tumor microenvironment-driven subtypes of invasive lobular carcinoma.
(pnas.org)
|
Serra M
…
Sotiriou C
PNAS
2026-02-10
|
#transcriptomics
#cancer
#microenvironment
#heterogeneity
#classification
|
|
0
|
|
KRAS-driven protein disulfide isomerase family A member 6 expression suppresses PRKR-like endoplasmic reticulum kinase-mediated immunogenic cell death to desensitise pancreatic ductal adenocarcinoma to immune checkpoint blockers.
(gut.bmj.com)
|
Wang R
…
Su H
Gut
2026-02-10
|
#amr
#cancer
#immunotherapy
#immunogenicity
#tumor microenvironment
|
|
0
|
|
SDC1(+) CAFs secreting CTGF drive tumour metastasis via FGFR3 signalling in cancers.
(gut.bmj.com)
|
Gao GF
…
Bei JX
Gut
2026-02-10
|
#transcriptomics
#cancer
#signaling
#metastasis
#fibroblast
|
|
0
|
|
Modulating the gut-reproductive tract axis: microbial influence on gynaecological cancer pathogenesis and treatment.
(gut.bmj.com)
|
Chen X
…
Zhao F
Gut
2026-02-10
|
#microbiome
#metabolism
#immunity
#dysbiosis
#cancer
|
|
0
|
|
Next-generation anti-DLL3 radiopharmaceuticals targeting high-grade neuroendocrine lung and prostate cancers.
(pnas.org)
|
Tendler S
…
Lewis JS
PNAS
2026-02-10
|
#antibody
#cancer
#immunotherapy
#neuroendocrine
#radiopharmaceuticals
|
|
0
|
|
Trogocytosis-orchestrated CLDN18.2-"dressed" CD8(+) T cells drive pancreatic cancer progression via glucose metabolic reprogramming-induced cytotoxicity debilitation and systematic immune senescence cascade.
(gut.bmj.com)
|
Zhou T
…
Hao J
Gut
2026-02-10
|
#metabolism
#cancer
#immunotherapy
#cytotoxicity
#pancreatic
|